Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Hannah Deborah Müller"'
Autor:
Nadia Dandachi, Florian Posch, Ricarda Graf, Christoph Suppan, Eva Valentina Klocker, Hannah Deborah Müller, Jörg Lindenmann, Angelika Terbuch, Ellen Heitzer, Marija Balic
Publikováno v:
Molecular Oncology, Vol 15, Iss 9, Pp 2390-2400 (2021)
Despite improved clinical outcomes, intrinsic or acquired resistance to CDK4/6 inhibitor treatment has limited the success of this treatment in HR+HER2− metastatic breast cancer patients. Biomarkers are urgently needed, and longitudinal biomarker m
Externí odkaz:
https://doaj.org/article/117d480dafe543e89c6b08c0fd35a25b
Autor:
Christoph Suppan, Ricarda Graf, Ellen Heitzer, Hannah Deborah Müller, Jörg Lindenmann, F. Posch, Marija Balic, Eva Valentina Klocker, Angelika Terbuch, Nadia Dandachi
Publikováno v:
Molecular Oncology, Vol 15, Iss 9, Pp 2390-2400 (2021)
Despite improved clinical outcomes, intrinsic or acquired resistance to CDK4/6 inhibitor treatment has limited the success of this treatment in HR+ HER2- metastatic breast cancer patients. Biomarkers are urgently needed, and longitudinal biomarker me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d58f2e858be1001b520d6dcf8029a78
https://doi.org/10.1002/1878-0261.12870
https://doi.org/10.1002/1878-0261.12870
Autor:
Hannah Deborah Müller, Melanie Gumpoldsberger, Herbert Stoeger, Hubert Hauser, Marija Balic, Nadia Dandachi, Sigurd F. Lax, Ute Bargfrieder, Robert Hammer, Kurt Prein, Florian Posch, Christoph Suppan
Publikováno v:
Annals of Surgical Oncology
Background Assessing the residual cancer burden (RCB) predictive performance, the potential subgroup effects, and time-dependent impact on breast cancer patients who underwent neoadjuvant therapy in a developer’s independent cohort is essential for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88c73d3b2e04e8b6e59302795a3f703f
https://doi.org/10.1245/s10434-019-07741-w
https://doi.org/10.1245/s10434-019-07741-w
Autor:
Nadia, Dandachi, Florian, Posch, Ricarda, Graf, Christoph, Suppan, Eva Valentina, Klocker, Hannah Deborah, Müller, Jörg, Lindenmann, Angelika, Terbuch, Ellen, Heitzer, Marija, Balic
Publikováno v:
Molecular Oncology
With longitudinal untargeted assessment of circulating tumor DNA in metastatic HR+ breast cancer patients during CDK4/6 treatment and joint model analyses, we demonstrated that tumor fraction trajectories rather than single time point measurements pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c9d6a53148fa9c4bbdc84b54a0fecd0b
https://pubmed.ncbi.nlm.nih.gov/33264486
https://pubmed.ncbi.nlm.nih.gov/33264486
Autor:
Florian Posch, Nadia Dandachi, Hannah Deborah Müller, Marija Balic, Herbert Stöger, Eva Valentina Klocker, Elisabeth Christina Henzinger, Daniel Steiner, Christoph Suppan
Publikováno v:
Breast Care (Basel)
Background: The addition of trastuzumab to standard chemotherapy has improved survival in patients with HER2-positive breast cancer in neoadjuvant, adjuvant, and metastatic settings. In higher tumor stages, the addition of pertuzumab is now a standar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::180ebe827500bf2affb127e7c5991604
https://pubmed.ncbi.nlm.nih.gov/35082570
https://pubmed.ncbi.nlm.nih.gov/35082570